文献速递主动脉疾病

肌少症预测腹主动脉瘤腔内修复术后长期生存不良

Sarcopenia predicts poor long-term survival in patients undergoing endovascular aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2017-08-26

该回顾性队列纳入2010年12月至2016年3月在一家退伍军人医院接受EVAR的135例患者,以L4上终板下缘轴位CT测得的腰大肌总面积(TPA)评估肌少症。最低三分位TPA者5年生存率为42%,其余三分之二为93%(P=.01);多因素分析示最低三分位TPA(OR 3.9,95%CI 1.2-12.9)与慢性肾病(OR 5.2,95%CI 1.5-18.0)与5年死亡风险升高相关,而低TPA与住院时间延长无关(P=.40)。

要点

  • 术前低腰大肌面积与EVAR后5年生存率显著降低相关。
  • 低TPA未预测住院时间延长,主要延迟出院原因为呼吸并发症与尿潴留。
  • 该简单术前测量或有助于个体化修复阈值、避免无获益手术。

核心结论

  • 术前肌少症不影响住院时间,但预示EVAR术后长期生存更差。
  • 该简单术前测量可能帮助血管外科医生调整修复阈值并避免无获益手术。

研究设计与样本

  • 回顾性队列研究,纳入2010年12月至2016年3月在一家退伍军人医院接受EVAR的全部135例患者。
  • 肌少症以L4上终板下缘轴位CT测得的总腰大肌面积(TPA)评估,结局取自病历记录。

主要发现

  • 患者中位年龄70岁,中位动脉瘤直径5.5 cm。
  • 25%患者(n=33)住院时间>2天,延迟出院最常见原因为呼吸并发症(8.9%[n=12])和尿潴留(4.0%[n=9])。
  • 低TPA与住院时间延长无关(P=.40)。
  • 最低三分位TPA患者5年生存率42%,其余三分之二患者为93%(P=.01)。
  • 多因素分析示最低三分位TPA(OR 3.9;95%CI 1.2-12.9)及慢性肾病(OR 5.2;95%CI 1.5-18.0)与5年死亡风险升高相关。

临床怎么用

  • 术前CT测量L4水平腰大肌总面积可辅助评估EVAR候选者的长期生存风险。
  • 对合并肌少症或慢性肾病者应审慎权衡EVAR获益,个体化修复阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sarcopenia measured by decreased psoas muscle size has been used as a surrogate for frailty and correlates with adverse outcomes in both the short and long term after many major operations. Our aim was to evaluate this measure as a predictor of outcomes in patients undergoing endovascular aortic aneurysm repair (EVAR). METHODS: Once Institutional Review Board approval was obtained, all patients who underwent EVAR from December 2010 to March 2016 at a Veterans Affairs hospital were assessed for sarcopenia by total psoas muscle area (TPA) measured on axial computed tomography scan immediately inferior to the fourth lumbar (L4) superior end plate. Outcomes including length of stay and mortality were collected from the medical record. RESULTS: There were 135 patients who underwent EVAR at a median age of 70 years. Median aneurysm size was 5.5 cm. Length of stay was >2 days in 25% of patients (n = 33), with the most common reasons for delayed discharge including respiratory complications (8.9% [n = 12]) and urinary retention (4.0% [n = 9]). Low TPA was not associated with extended length of stay (P = .40). Patients with lowest tertile TPA had 42% 5-year survival compared with 93% survival observed for the remaining two-thirds of patients (P = .01). Multivariate analysis revealed increased likelihood of mortality at 5 years for patients in the lowest tertile for TPA (odds ratio, 3.9; 95% confidence interval, 1.2-12.9) as well as for patients with chronic kidney disease (odds ratio, 5.2; 95% confidence interval, 1.5-18.0). CONCLUSIONS: Preoperative sarcopenia does not appear to affect length of stay but does portend worse long-term survival. This simple preoperative measurement may help vascular surgeons tailor repair thresholds and avoid nonbeneficial procedures.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Newton DH, Kim C, Lee N, et al. Sarcopenia predicts poor long-term survival in patients undergoing endovascular aortic aneurysm repair. J Vasc Surg. 2017. PMID: 28847662. doi:10.1016/j.jvs.2017.06.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。